Things to know about bio-drugs as Samsung unit goes public

Samsung BioLogics, whose shares made their debut on the Seoul stock market in an IPO Thursday, is the biopharmaceutical manufacturing unit of South Korean giant Samsung. It aims to become a world leader in the outsourced production of biologic drugs. What are biologic drugs?